Weighted Average Number of Shares Outstanding, Diluted of Vor Biopharma Inc. from Q2 2021 to Q3 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Vor Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2025.
- Vor Biopharma Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 6.68M shares, a 95.2% increase year-over-year.
- Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 68.7M shares, a 2.25% increase from 2023.
- Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 67.2M shares, a 69.9% increase from 2022.
- Vor Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 39.6M shares, a 18.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)